Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Launched by UNIVERSITY OF SPLIT, SCHOOL OF MEDICINE · Oct 20, 2017

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods to help treat a condition called pterygium, which is a noncancerous growth on the eye that can cause vision problems and other concerns. The study is comparing the use of cauterization (a technique that uses heat to prevent bleeding) versus fibrin glue (a special type of adhesive) for a procedure called conjunctival autografting, where a piece of tissue from the eye is moved to cover the area where the pterygium was removed. The goal is to find out which method is better at preventing the pterygium from coming back after surgery.

To participate in this trial, you need to be an adult over 18 years old and have a primary pterygium that is larger than 4 mm. This means that if you have this growth and are experiencing vision issues, inflammation, or cosmetic concerns, you may be eligible. If you have had previous eye surgery or certain health conditions, you may not be able to join. Participants will be randomly assigned to one of the two treatment groups and will receive care from medical professionals throughout the study. This trial is currently recruiting participants, and both men and women are welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • adults (older than 18 years of age)
• • both sexes
• • primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
• • if the patients had a bilateral pterygium, only one eye will be operated
• Exclusion criteria:
• • connective tissue disease
• • prior eye surgery
• • chronic use of topical drugs (anti-glaucoma drugs)